Related Articles
ESMA issues new Q&A on alternative performance measures in the context of COVID-19
The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, has issued a Q&A to provide guidance to issuers on the application of the ESMA Guidelines on Alternative Performance Measures (APM Guidelines) in the context of the COVID-19 pandemic. The Q&A published today highlights the main principles of the APM Guidelines; encourages […]
ESMA clarifies external support within the meaning of Article 35 of the MMF Regulation
The European Securities and Markets Authority (ESMA), the EU securities markets regulator, today publishes a public statement on external support under Article 35 of the Money Market Funds (MMF) Regulation. ESMA is issuing this statement in the context of financial markets authorities recent actions to mitigate the impact of COVID-19 on the EU’s financial markets, […]
ESAs propose to amend bilateral margin requirements to assist Brexit preparations for OTC derivative contracts
The draft RTS propose, in the context of the United Kingdom’s (UK) withdrawal from the European Union (EU), to introduce a limited exemption in order to facilitate the novation of certain OTC derivative contracts to EU counterparties during a specific time-window. The amendments would only apply if the UK leaves the EU without the conclusion […]